about
The dopamine metabolite 3-methoxytyramine is a neuromodulatorPharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensorThe APJ receptor: a new therapeutic approach in diabetic treatmentExpression of the murine msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vesselsApelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G proteinApelin, a newly identified adipokine up-regulated by insulin and obesityRegulation of Akt signaling by D2 and D3 dopamine receptors in vivoApelin promotes lymphangiogenesis and lymph node metastasis.Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactionsFunctional interaction between trace amine-associated receptor 1 and dopamine D2 receptorApelin signalling: a promising pathway from cloning to pharmacology.Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.Therapeutic potential of interfering with apelin signalling.Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.Apelin targets gut contraction to control glucose metabolism via the brain.Apelin receptors: From signaling to antidiabetic strategy.Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas.Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins.Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarctionThe apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments.Correction: The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator.[Apelin signalisation and vascular physiopathology].Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart.Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism.The Adaptor Protein Gab1 Couples the Stimulation of Vascular Endothelial Growth Factor Receptor-2 to the Activation of Phosphoinositide 3-KinaseExperimental challenge to a 'rigorous' BRET analysis of GPCR oligomerizationThe intestinal glucose-apelin cycle controls carbohydrate absorption in mice
P50
Q21091097-FE7BDE42-641B-4973-86FC-D35FEF02D297Q24627304-6C0D81E6-CC75-4D1A-98A8-1C78CABAF492Q27025069-6FAB1688-0015-4124-81F9-2A52E618BFA3Q28211274-35B511B7-EABC-4B4B-AE38-2125317942C5Q28214678-A2C3F3FB-50CF-4625-B271-DCB24C1514CBQ28304725-29D2AC4C-647D-4CA6-BB10-76A476454978Q28512114-57243933-2425-4B1C-AFAF-F701AC141440Q34100995-D4E2A416-D73C-469F-9FB8-10D3DDB1E407Q35049564-496890FB-1A8F-49C8-B146-40829880399DQ35188101-2BB11485-C48C-44E9-9CAE-55C98DE598BAQ35985615-7E3E70FB-BEFB-4237-97C3-78767FAF0F72Q36507158-7FBCCC32-F2D8-4021-A6CA-8C27942E3B6DQ36665676-894EC243-FAF2-474D-A147-336C101A3094Q36870038-1056EB7B-74B3-4AD9-AE8F-1771B3651670Q37617075-60C92CBD-FAC4-4FDC-8BF6-A4C515366E3BQ38501605-6EBDA7C3-FC1F-416B-9914-5C851E426EA3Q38938652-01E4E475-B171-450B-8E0A-83A00DABF1D8Q39046538-7A5B5A38-FF65-4863-A093-0A06181ED673Q40200987-26425BC1-4A43-4090-9176-B8851BF589DCQ41905591-541F106A-AEB7-4756-9208-4681EBF51F6BQ42126369-9676FEB1-81CF-4E41-BFCC-3110DA5E3635Q42494904-F9A90930-2906-43EF-9340-1C01BB14CE3DQ45945291-3E2DD0E9-A682-42FE-A266-C1A6DF4B2CF5Q45968613-7921C5F9-31E5-4B5A-8D13-C35FCE70FD01Q46566034-97CCBB92-E85E-4E61-A067-7AED898BBB59Q47295524-98A27533-647D-4B71-A6DB-C81F36CD6EBEQ48042174-34E297EE-6808-4E94-8741-CF2524A8F71DQ64355677-0C8997AC-87AD-414F-9967-AC5CADCB0646Q80705975-46656AD2-B729-440B-AECA-86B93995A706Q85892132-27A262A6-E83A-4D98-9872-8627115814AE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bernard Masri
@ast
Bernard Masri
@en
Bernard Masri
@es
Bernard Masri
@nl
type
label
Bernard Masri
@ast
Bernard Masri
@en
Bernard Masri
@es
Bernard Masri
@nl
prefLabel
Bernard Masri
@ast
Bernard Masri
@en
Bernard Masri
@es
Bernard Masri
@nl
P106
P1153
7006635205
P31
P496
0000-0002-4027-2604